
这个市场不值得进入,结论非常明确:新品牌几乎没有可复制的成功样本,而且已经出现明显的低利润、低成功率信号。 以当前数据看,市场不是机会型,而是试错型;对小卖家尤其不友好,对大品牌也不适合轻易切入。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不值得进入。 你的预算 50万CNY 表面上够覆盖单个ASIN的前期采购、物流和基础投放,但市场本身已经呈现出高竞争、低盈利的信号,尤其新品牌几乎没有成功样本,属于不适合现在切入的类型。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入:已经接近/处于价格战型高风险区,而且缺乏可复制的小卖家成功样本。 目前能看到的核心新入场品牌 Mensarix,2个新品里0个盈利,品牌盈利率0%,新产品盈利率0%,说明新品牌进来后基本没跑通;再叠加核心可见ASIN B0F3CBJXQM 虽然表面毛利率有32.1%,但实际仍被判定为非盈利,属于“看起来能赚、落地不赚钱”的典型。
这个市场不值得进入:新品牌只有 Mensarix,2 个新上架全部不盈利,整体成功率 0%,而且看不到任何成熟品牌的正向样本,说明不是机会市场,是试错市场。 你现在看到的不是“可复制的成功”,而是“两个新产品都没跑通”的早期失败样本;其中 B0F3CBJXQM 虽然卖到 55.07 美元、月销 50 件、月营收 2,753.50 美元,表面毛利率有 32.1%,但仍被判定为不盈利,原因是广告和履约后利润模型不稳定,且销量只有 50 件,远没到能证明健康放量的程度。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
![]() | B0F3CBJXQM | Mensarix | 2025-08-18 | No | $55.07 | 50pcs | $2753.5 | 32.07% | $883.05 |
![]() | B0H29NB5ZH | Mensarix | 2026-05-19 | No | $- | -pcs | $- | -% | $- |
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
![]() | B0F3CBJXQM | Mensarix | 2025-08-18 | No | $55.07 | 50pcs | $2753.5 | 32.07% | $883.05 |
![]() | B0H29NB5ZH | Mensarix | 2026-05-19 | No | $- | -pcs | $- | -% | $- |
这个市场不值得进入,结论很直接:新品牌几乎没有合法成功空间,且整体已经进入极度竞争状态。 目前可见样本里,新品盈利率是0%,新品牌新品盈利率也是0%,连品牌 Mensarix 的2个新产品都全部亏损;这不是单点失误,而是典型的高压价格战市场。
What is the ratio of profitable products
What is the ratio of different brands owning all nonprofitable new products
这个市场不适合进入,结论很明确:新品牌已经连续失败,且没有任何真实的新品牌盈利案例。 目前看到的不是可复制的机会,而是一个高投入、低回报、对新入场者极不友好的市场。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |